Clinical Trial Update: Improving Blood Stem Cell Collection and Transplant Procedures [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update focused on improving blood stem cell collection and transplant procedures, completed with results reported by NHLBI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Lymphocytic Leukemia
• Myelodysplastic Syndrome
• Myelogenous Leukemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia | Phase 1, Phase 2 | Status: COMPLETED